
A Biomarker for Better Response in IDH1- or IDH2-Mutated AML
Author(s) -
Sarah LaCorte
Publication year - 2022
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000822064.27835.4b
Subject(s) - medicine , cohort , myeloid leukemia , oncology , idh1 , idh2 , biomarker , medical physics , mutation , biology , genetics , gene